Mineralocorticoid insufficiency due to suramin therapy

Cancer

Volumn 78, Issue 11, 1996, Pages 2411-2420

  Kobayashi, Ken ^a,c   Weiss, Roy E ^a   Vogelzang, Nicholas J ^a,b,d   Vokes, Everett E ^a,b   Janisch, Linda ^a   Ratain, Mark J ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

^c Division of Oncology Drug Products   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

adrenal cortical insufficiency; dose response; dose toxicity; fludrocortisone; glucocorticoid; hydrocortisone; mineralocorticoid; suramin

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; SURAMIN; TETRACOSACTIDE;

ADRENAL CORTEX INSUFFICIENCY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN TEST; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOIMMUNOASSAY;

ADDISON DISEASE; ADRENAL CORTEX DISEASES; ADRENOCORTICOTROPIC HORMONE; AGED; ALDOSTERONE; ANTINEOPLASTIC AGENTS; COSYNTROPIN; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURAMIN;

EID: 0029806192     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2411::AID-CNCR20>3.0.CO;2-2     Document Type: Article

References (40)

1. Davies JP, Bentley P, Ghose RR. Aminoglutethimide-induced hyperkalaemia. Br J Clin Pract 1988;43(7):263-4.
2. Calabresi P, Chabner BA. Antineoplastic agents. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics. 8th edition. New York: Pergamon Press, 1990:1209-63.
3. Sharkey PK, Rinaldi MG, Dunn JF, Hardin TC, Fetchik RJ, Graybill JR. High-dose itraconazole in the treatment of severe mycoses. Antimicrob Agents Chemother 1991;35(4):707-13.
4. Tucker WS, Snell BB, Island DP, Gregg CR. Reversible adrenal insufficiency induced by ketoconazole. JAMA 1985; 253(16):2413-4.
5. Haynes RC Jr. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics. 8th edition. New York: Pergamon Press, 1990:1431-62.
6. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984;310:1415-21.
7. Elansary EH, Earis JE. Rifampicin and adrenal crisis. BMJ 1983;286:1861-2.
8. Edwards OM, Courtney-Evans RJ, Galley JM, Hunter J, Tait AD. Changes in cortisol metabolism following rifampicin therapy. Lancet 1974;2:549-51.
9. Kyriazopoulou V, Parparousi O, Vagenakis AG. Rifampicin-induced adrenal crisis in Addisonian patients receiving corticosteroid replacement therapy. J Clin Endocrinol Metab 1984;59:1204-6.
10. Wilkins EGL, Hnizdo E, Cope A. Addisonian crisis induced by treatment with rifampicin. Tubercle 1989;70:69-73.
11. Prior J, White I. Addisonian syndrome associated with treosulfan. Lancet 1978;2:1207-8.
12. O'Kelly R, Magee G, McKenna TJ. Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endocrinol Metab 1983;56(1):108-12.
13. Brohee D, Neve P. Heparin side effects. Arch Intern Med 1984;144:1693.
14. Wilson ID, Goetz FC. Selective hypoaldosteronism after prolonged heparin administration. Am J Med 1964;36:635-40.
15. Kloppenborg PW, Casparie AF, Benraad TJ, Majoor CL. Inhibition of adrenal function in man by heparin or heparinoid Ro 1-8397. Acta Medica Scandinavia 1975;197(1-2):99-108.
16. Leehey D, Gantt C, Lim V. Heparin-induced hypoaldosteronism: report of a case. JAMA 1981;246(19):2189-90.
17. Ward PD, Carter G, Banks R, MacGregor G. Trilostane as a cause of Addisonian crisis. Lancet 1981;2:1178.
18. Stein CA, Saville W, Yarchoan R, Broder S, Gelmann EP. Suramin and function of the adrenal cortex. Ann Intern Med 1986;104:286-7.
19. Kobayashi K, Vokes EE, Vogelzang NJ, Janisch L, Soliven B, Ratain MJ. A phase I study of suramin (NSC 34936) given by intermittent infusion without adaptive control in patients with advanced cancer. J Clin Oncol 1995;13:2196-207.
20. Dluhy RG, Himathongkam T, Greenfield M. Rapid ACTH test with plasma aldosterone levels: improved diagnostic discrimination. Ann Intern Med 1974;80:693-8.
21. Williams GH, Dluhy RG. Diseases of the adrenal cortex. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, et al., editors. Harrison's principles of internal medicine. 12th edition. New York: McGraw-Hill, Inc., 1991:1713-35.
22. Kaiser L. Adjusting for baseline: change or percentage change? Stat Med 1989;8:1183-90.
23. Norusis MJ. SPSS for Windows User's Guide. Chicago: SPSS Inc, 1993.
24. Gibaldi M, Perrier D. Pharmacokinetics. 2nd edition. Volume 15. New York: Marcel Dekker, Inc., 1982.
25. Jacobs TP, Whitlock RT, Edsall J, Holub DA. Addisonian crisis while taking high-dose glucocorticoids: an unusual presentation of primary adrenal failure in two patients with underlying inflammatory diseases. JAMA 1988;260(14):2082-4.
26. Hurley D, Accili D, Stratakis C, Karl M, Vamvakopoulos N, Rorer E, et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 1991;87(2):680-6.
27. Eisenberger MA, Sinibaldi VJ, Reyno LM, Sridhara R, Jodrell DI, Zuhowski EG, et al. Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer. J Clin Oncol 1995;13(9):2174-86.
28. Heppner C, Petzke F, Arlt W, Mbulamberi D, Siekmann L, Vollmer D, et al. Adrenocortical insufficiency in Rhodesian sleeping sickness is not attributable to suramin. Trans R Soc Trop Med Hyg 1995;89(1):65-8.
29. Redman BG, Pazdur R, Zingas AP, Loredo R. Prospective evaluation of adrenal insufficiency in patients with adrenal metastasis. Cancer 1987;60:103-7.
30. Mirtsching BC, Freeman DA. Adrenal insufficiency and stage D carcinoma of the prostate. South Med J 1992;85(2):196-7.
31. Marzouk HFAI, Hofland LJ, den Holder FH, van Koetsveld PM, Steenbergen J, Zuiderwijk J, et al. Effects of suramin on hormone release by cultured rat anterior pituitary cells. Mol Cell Endocrinol 1990;72:95-102.
32. Dorfinger K, Niederle B, Vierhapper H, Astrid W, Czernin S, Nowotny P, et al. Suramin and the human adrenocortex: results of experimental and clinical studies. Surgery 1991; 110:1100-5.
33. Dorfinger K, Vierhapper H, Wilfing A, Czernin S, Niederle B, Nowotny P, et al. The effects of suramin on human adrenocortical cells in vitro: suramin inhibits cortisol secretion and adrenocortical cell growth. Metabolism 1991;40(10):1020-4.
34. Ashby H, DiMattina M, Linehan WM, Robertson CN, Queenan JT, Albertson BD. The inhibition of human adrenal steroidogenic enzyme activities by suramin. J Clin Endocrinol Metab 1989;68(2):505-8.
35. Marzouk HFAI, Zuyderwijk J, Uitterlinden P, de Jong FH, Lamberts SWJ. Suramin prevents ACTH-stimulated corticosterone release by dispersed adrenocortical cells. Endocrinology 1990;126(1):666-8.
36. Zenatti M, Blanchouin-Emeric N, Koplewicz S, Defaye G, Aupetit-Faisant B. Suramin: an inhibitor of the final steps of the mineralocorticoid pathway? J Steroid Biochem Mol Biol 1994;48(2/3):265-70.
37. Feuillan P, Raffeld M, Stein CA, Lipford N, Rehnquist D, Meyers CE, et al. Effects of suramin on the function and structure of the adrenal cortex in the cynomolgus monkey. J Clin Endocrinol Metab 1987;65(1):153-8.
38. Humphreys EM, Donaldson L. Degeneration of the adrenal cortex produced by germanin. Am J Pathol 1941;17:767-75.
39. Mahoney LJ, Barrie HJ. Adrenal insufficiency after suramin treatment of pemphigus. BMJ 1950;2:655-6.
40. Wells HG, Humphreys EM, Work EG. Significance of the increased frequency of selective cortical necrosis of adrenal as a cause of Addison's disease. JAMA 1937; 149(7):490-3.